EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS39 - Drug allergy 3

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
A Retrospective Analysis of Drug Provocation Tests in Children with Underlying Conditions
Allergic contact dermatitis due to neomycin in a child: cross-reactivity study
Asymptomatic Eosinophilia Associated With Garcinia Cambogia Use
Childhood vaccinations in children with food or vaccination related allergic reactions- A single center experience
Evaluating aryl hydrocarbon receptor activity modulation by drugs associated with cutaneous adverse drug reactions
Evaluation of clinical features and diagnostic tests in pediatric patients with suspected hypersensitivity reactions to proton pump inhibitors
Evaluation of frequency and characteristics of radiocontrast media hypersensitivity reactions in children
Harmony and disharmony between studies regarding cross allergy in β-lactam antibiotic allergy
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity Reactions: An approach to assessment, diagnosis, and management in a paediatric population
One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: patient profile, protocol and tolerability
Piperacillin-tazobactam Fever in Children with Cystic Fibrosis: Incidence and Clinical Features
Reflection on the Role of Basophil Activation Test in the Diagnosis of Pediatric Drug Allergy
Successful Rapid Liposomal Amphotericin-B Desensitization in Pediatric Case Series and Literature Review
Twenty-Five Years’ Experience with Immediate-Type Local Anesthetic Reactions in Children
Visiting the emergency room with a drug allergy label. Our experience in real life

Chairs

Speakers